Year: 2019

EVLI PANKKI OYJ:N PÖRSSITIEDOTE 20.12.2019 KLO 10.35Vuoden viimeinen neljännes on sujunut liiketoiminnallisesti hyvin sekä varainhoito- ja sijoittaja-asiakkaat -segmentissä että neuvonanto- ja yritysasiakkaat -segmentissä. Lisäksi yleinen osake- ja korkomarkkinoiden kehitys on ollut suotuisaa. Tämän takia yhtiö tarkentaa näkymiään vuodelle 2019.Positiivisen kehityksen seurauksena arviomme vuoden 2019 liikevoiton ylittävän vertailukauden tason.Aiemmin totesimme, että kannattavan ja vakaan kehityksen seurauksena arviomme vuoden 2019 liikevoiton säilyvän vertailukauden tasolla tai ylittävän sen.EVLI PANKKI OYJLisätietoja: Maunu Lehtimäki, toimitusjohtaja, Evli Pankki Oyj, p. 050 553 3000, maunu.lehtimaki@evli.comJuho Mikola, talousjohtaja,...

Press Release20 December 2019Immunicum AB (publ) Announces Upcoming Oral Presentation on MERECA Trial at the ASCO-SITC Clinical Immuno-Oncology SymposiumImmunicum AB (publ; IMMU.ST) announced today that the abstract covering data from the Phase II MERECA trial has been accepted for an oral presentation at the ASCO-SITC Clinical Immuno-Oncology Symposium, which will be held February 6-8, 2020 in Orlando, Florida. The MERECA trial investigated the therapeutic benefit of combining Immunicum’s lead product, ilixadencel, and Sutent® (sunitinib) as a first-line treatment in patients with metastatic kidney cancer. Immunicum announced top-line results from the study in the third quarter of 2019 and will present more detailed results at the symposium, including the first half-yearly follow-up of patient survival in the study.“Only...

Pressmeddelande20 december 2019Immunicums MERECA-studie utvald för muntlig presentation vid ASCO-SITC Clinical Immuno-Oncology SymposiumImmunicum AB (publ) meddelade i dag att abstraktet med data från fas II-studien MERECA har valts ut för en muntlig presentation vid ASCO-SITC Clinical Immuno-Oncology Symposium den 6-8 februari 2020 i Orlando, Florida. I MERECA-studien undersöktes behandlingseffekten av ilixadencel, Immunicums ledande läkemedelskandidat, i kombination med Sutent® (sunitinib) som en första linjens behandling av patienter med metastaserad njurcancer. Immunicum meddelade topline-resultat från studien under det tredje kvartalet 2019 och kommer att presentera mer detaljerade resultat under symposiet, inklusive den första halvårsvisa uppföljningen av överlevnaden...

Company announcement no. 43 – 19 20 December 2019NTG Nordic Transport Group A/S acquires 85% of the shares in Ebrex Business Solutions Ltd.NTG Nordic Transport Group A/S (“NTG”) has today entered into a share purchase agreement whereby NTG will acquire 85% of the shares in Ebrex Business Solutions Ltd. (“Ebrex”). The transaction was described in NTG’s Prospectus dated 24 September 2019 as a potential material transaction where a letter of intent had been signed.Ebrex is headquartered in Great Yarmouth, United Kingdom and has its core business areas in road freight forwarding, supply chain solutions and warehousing, mainly to the automotive aftermarket industry in Continental Europe (spare parts). The key geographical markets are United Kingdom, Germany, Poland and Sweden.Ebrex was founded in 1985 and...

LONDON, Dec. 20, 2019 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (“NMPA”) has granted Priority Review status to the New Drug Application (“NDA”) for surufatinib for the treatment of patients with advanced non-pancreatic neuroendocrine tumors (“NET”).“Surufatinib is our second drug to be granted priority review by the NMPA,” says Christian Hogg, Chief Executive Officer of Chi-Med. “We are working closely with the NMPA as they review our NDA for the treatment of non-pancreatic NET. Surufatinib being granted priority review is a positive step forward in potentially bringing this innovative drug to patients, who currently...

Shell fourth quarter 2019 update noteThe Hague, December 20, 2019 – This is an update to the fourth quarter 2019 outlook provided in the third quarter results announcement on October 31, 2019. The impacts presented here may vary from the actual results and are subject to finalisation of the fourth quarter 2019 results which are scheduled to be released on January 30, 2020.Unless otherwise indicated, presented earnings impacts relate to earnings on a current cost of supplies basis, attributable to shareholders, excluding identified items.Integrated GasProduction is expected to be between 920 and 970 thousand barrels of oil equivalent per dayLNG liquefaction volumes are expected to be between 8.8 and 9.4 million tonnesTrading and optimisation performance is expected to be average and approximately in line with the second quarter 2019As...

LONDON, Dec. 20, 2019 (GLOBE NEWSWIRE) — Horizonte Minerals Plc, (AIM/TSX: HZM) (‘Horizonte’ or the ‘Company’) the nickel development company focused in Brazil, is pleased to announce an update on its Corporate Social Responsibility (‘CSR’) program in the communities surrounding its Araguaia Nickel Project (‘Araguaia’), south of the Carajás Mining District in the Pará State, north east Brazil.Key HighlightsHorizonte has supported local communities since its initial discovery of the project; The Company is running several new social impact projects, tackling issues specific to the region, in partnership with local community organisations; These projects include:Strengthening the local supply chain;Sex education and reproductive health; andDiversification of the...

ING to appoint Pinar Abay as head of Market Leaders and member of the Management Board BankingING announced today that Pinar Abay will be appointed member of the Management Board Banking and head of Market Leaders, taking up the responsibility for ING’s operations in the Benelux. She will take up her new position per 1 January 2020.Pinar Abay (Turkish, 1977) currently is country manager of ING in Turkey, a role she has held since joining ING in 2011. Before that Pinar was a partner at McKinsey & Company in Turkey, in charge of consultancy for the banking sector. She started at McKinsey in Istanbul in 1998 and also worked in San Francisco and New York. Since 2016 she has been a non-executive director of ING in Belgium. Pinar studied economics at Bilkent University in Turkey and has an MBA from Harvard Business School.Ralph Hamers,...

TencentOS Tiny LoRaWAN availability on STM32 products simplifies LoRaWAN node-to-cloud migration to Tencent Cloud IoT ExplorerShenzhen, China, December 20, 2019 – At Tencent Cloud IoT Ecosystem Summit 2019, Tencent Cloud IoT Division of Tencent Group (HK: 0700), and STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announce their cooperation on Tencent’s latest IoT operation system, TencentOS Tiny LoRaWAN. Through TencentOS Tiny LoRaWAN running on STM32 LoRaWAN® software expansion package, this cooperation will allow simple, seamless access to the one-stop software solutions on the Tencent Cloud IoT Explorer platform for faster time-to-market of large-volume IoT applications.TencentOS Tiny is an open-source compact IoT embedded operation system...

Honkarakenne sponsors Tuuli Petäjä-Sirén on her journey to the Tokyo OlympicsPRESS RELEASE 20 December 2019Honkarakenne is co-sponsoring windsurfer Tuuli Petäjä-Sirén on her journey to the Tokyo summer Olympics of 2020. Outside her sporting career, Petäjä-Sirén, who will represent Finland in the RS:X windsurfing class at the Olympics, is an architect at Honkarakenne. As part of their partnership, Tuuli will design a log cabin collection inspired by the natural landscape of the Finnish archipelago. The collection will be launched in early 2020.Petäjä-Sirén won silver medal at the London Olympics of 2012 and came tenth at Rio in 2016. In addition to competitive sailing, this Olympic medal winner has qualified as an architect and began work for Honkarakenne in 2017. Tuuli’s...